[Pancreatitis and inappropriate ADH secretion syndrome associated with amiodarone].
We describe a case of hepatotoxicity, pancreatitis and inappropriate ADH secretion syndrome developed in a patient receiving chronic amiodarone treatment, not related to other causes. Hepatic toxicity is a well known condition. Inappropriate ADH secretion syndrome has not been described yet and there has been a single case-report of pancreatitis in the literature reviewed.
Muñoz Ruiz
A I
AI
Servicio de Medicina Interna I, Hospital General Gregorio Marañón Madrid.
Calvo Elipe
A
A
Guerrero Vega
E
E
Gorgojo Martínez
J J
JJ
Vera López
E
E
Gilsanz Fernández
C
C
D000368:Aged; D000638:Amiodarone / Q000009:adverse effects*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D001281:Atrial Fibrillation / Q000188:drug therapy; D056486:Chemical and Drug Induced Liver Injury / Q000150:complications / Q000209:etiology; D006801:Humans; D007177:Inappropriate ADH Syndrome / Q000139:chemically induced* / Q000150:complications; D008297:Male; D010195:Pancreatitis / Q000139:chemically induced* / Q000150:complications
D000889:Anti-Arrhythmia Agents; D000638:Amiodarone
Pancreatitis y síndrome de secreción inadecuada de ADH asociados a amiodarona.